.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
McKinsey
US Department of Justice
McKesson
Julphar
Queensland Health
Deloitte
Colorcon
Chinese Patent Office
Covington

Generated: September 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050006

« Back to Dashboard
NDA 050006 describes VIBRAMYCIN, which is a drug marketed by Pfizer and is included in four NDAs. It is available from two suppliers. Additional details are available on the VIBRAMYCIN profile page.

The generic ingredient in VIBRAMYCIN is doxycycline calcium. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxycycline calcium profile page.

Summary for NDA: 050006

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Dermatological Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 050006

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIBRAMYCIN
doxycycline
FOR SUSPENSION;ORAL 050006 NDA Pfizer Laboratories Div Pfizer Inc 0069-0970 0069-0970-65 60 mL in 1 BOTTLE (0069-0970-65)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrengthEQ 25MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Covington
Boehringer Ingelheim
Johnson and Johnson
Dow
Chubb
Argus Health
Cantor Fitzgerald
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot